Recent Security Class Actions

Adamas Pharmaceuticals Inc. Common Stock (NASDAQ: ADMS)

Company Name:Adamas Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: ADMS
Class Period Start:08/08/2017
Class Period End (inclusive):03/04/2019
Filing Deadline:02/08/2020

According to the Complaint, Adamas Pharmaceuticals, Inc. is a commercial stage pharmaceutical company that specializes in developing drug treatment therapies for chronic neurologic disorders.

The Complaint alleges that throughout the Class Period, Adamas' public statements were false and materially misleading.